120 related articles for article (PubMed ID: 3789753)
1. [Studies on the enhancement of anti-tumor activity in patients with cervical cancer by local administration of OK-432].
Yamada Y; Yamamoto K; Wakita K; Shiraki S; Noda K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3427-31. PubMed ID: 3789753
[TBL] [Abstract][Full Text] [Related]
2. Modulation of NK activity in regional lymph nodes by preoperative immunotherapy with OK-432 in patients with cancer of the oral cavity.
Vinzenz K; Matejka M; Watzek G; Porteder H; Neuhold N; Micksche M
Cancer Detect Prev Suppl; 1987; 1():463-75. PubMed ID: 3480060
[TBL] [Abstract][Full Text] [Related]
3. [Study on enhancement of antitumor immunity in cervical cancer--with reference to administration of immunopotentiators].
Wakida K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):432-8. PubMed ID: 3559328
[TBL] [Abstract][Full Text] [Related]
4. [Effects of preoperative local administration of BRM on cellular immunity and prognosis of patients with esophageal cancer].
Tanaka Y; Miyama T; Suda Y; Fujita K; Takubo K
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1780-3. PubMed ID: 1877817
[TBL] [Abstract][Full Text] [Related]
5. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer].
Yamane T; Sagara Y; Suzuki G; Kasuga M; Sakita M; Fujita Y; Majima S
Gan To Kagaku Ryoho; 1984 Apr; 11(4):930-4. PubMed ID: 6721507
[TBL] [Abstract][Full Text] [Related]
6. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study on the effect of intratumoral administration of OK-432 on breast cancer--anti-tumor immune response at the site of local injection].
Hosokawa T
Nihon Geka Gakkai Zasshi; 1991 May; 92(5):577-86. PubMed ID: 1831533
[TBL] [Abstract][Full Text] [Related]
8. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
Kobayashi G
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):68-76. PubMed ID: 2314383
[TBL] [Abstract][Full Text] [Related]
9. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
[TBL] [Abstract][Full Text] [Related]
10. [Endoscopic administration of OK-432 in gastric cancer].
Inbe A; Sumii K; Haruma K; Uemura N; Tari A; Yoshihara M; Tokutomi T; Inaba Y; Sekito M; Ogoshi H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):514-9. PubMed ID: 3954375
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody to the streptococcal preparation OK-432: tissue OK-432 localization and analysis of interaction between OK-432 and macrophages or NK cells in human salivary adenocarcinoma-bearing nude mice given OK-432.
Sato M; Kaji R; Urata M; Yoshida H; Yanagawa T; Miyamoto K; Azuma M; Furumoto N; Saito M
J Biol Response Mod; 1988 Apr; 7(2):212-28. PubMed ID: 3361352
[TBL] [Abstract][Full Text] [Related]
12. [Effective mechanisms of BRM, with special reference to induction of autologous tumor cell-killing (ATK) activity by OK-432].
Hoshino T; Uchida A
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1277-84. PubMed ID: 3488024
[TBL] [Abstract][Full Text] [Related]
13. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
[TBL] [Abstract][Full Text] [Related]
14. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical studies on local antitumor effects of streptococcal immunopotentiator, OK-432, in human solid malignant tumors.
Sugenoya A; Usuda N; Adachi W; Kaneko G; Nagata T; Iida F
Arch Pathol Lab Med; 1988 May; 112(5):545-9. PubMed ID: 3282486
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of immunological response of regional lymph node lymphocytes from patients with gastric cancer after endoscopic local injection of biological response modifier (BRM)].
Obi Y
Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):293-302. PubMed ID: 2051981
[TBL] [Abstract][Full Text] [Related]
17. [Local immunotherapy for cancer].
Hattori T; Niimoto M; Toge T; Hamamoto S; Seto Y; Kameda A; Tomoda S
Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1157-61. PubMed ID: 6503978
[TBL] [Abstract][Full Text] [Related]
18. [Effect of selective intra-arterial infusion of OK-432 against renal cell cancers].
Fujioka T; Tanji S; Koike H; Kumagai K; Suzuki K; Aoki H; Banya Y; Kubo T; Ohhori T
Hinyokika Kiyo; 1987 Jun; 33(6):832-7. PubMed ID: 3673835
[TBL] [Abstract][Full Text] [Related]
19. [Experimental study of oral administration of streptococcal preparation "OK-432". The third report: its enhancing effects on natural killer activity and lymphoproliferative response to mitogens of mouse mesenteric lymph node].
Nio Y; Inamoto T; Kan N; Hori T; Nakayama N; Yamasaki N; Hikasa Y; Tsuchitani T; Ban S; Nagai T
Nihon Gan Chiryo Gakkai Shi; 1984 May; 19(4):803-10. PubMed ID: 6491430
[No Abstract] [Full Text] [Related]
20. [Metastatic behavior of footpad-inoculated tumors in mice and the impact of OK-432 per os administration].
Nakajima Y; Akimoto M; Kimura M; Iwasaki H; Matano S; Hirakawa H; Mori S
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1229-33. PubMed ID: 3579323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]